Max Neeman International Report issue

For profit Phase 3
Founded: New Delhi India (2001)
Status: Acquired by JSS Medical Research Inc. (2015)

Organization Overview

First Clinical Trial
2009
NCT01017614
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Max Neeman

Active Ingredients

Drugs in Phase 3 Trials (2)

ferric sulfate (1 trial)

iron isomaltoside (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 3)

Anemia, Iron-Deficiency (Phase 3)

Inflammatory Bowel Diseases (Phase 3)

Intestinal Diseases (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2